CEO SUMMARY: Cytyc, NeoPath and Neuromedical each tapped the public capital markets during the past 18 months. Now investors expect to see earnings growth and dividends as soon as possible. Clinical laboratories should expect intensified sales and marketing efforts from these three companies as they strive to increase sales. Probably the most ubiquitous sales representatives […]
- "Pap Smear Wars Intensify"
Pap Smear Technologies Battle For Market Share
Investors pressure competing companies to increase sales volume and earnings
- By Robert Michel
- > From the Volume IV No. 9 - June 23, 1997 Issue
- Tags: automation systems, cap, clinical integration, clinical lab, clinical laboratories, commercial laboratory, cytology laboratory, dark report, laboratories, laboratory automation system, laboratory automation systems, laboratory executive, laboratory tech, laboratory technology, lis software, managed care, Medicare, private payer, quality control, smear test, specimen preparation, the dark report, the laboratory
